Genetic Technologies Ltd has released a press release.
GeneType Multi-Test Approved for Commercial Release
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Quarterly Activities Report & Appendix 4C
- Momentum Building with Cash Receipts up 112% for Q2 FY22
- GTG delivers material increase in cash receipts
- Presentation to H.C. Wainwright Investment Conference
- Genetic Technologies FY21 Full Year Results
Later from Genetic Technologies
- US Patent Office Grants Patent for COVID-19 Risk Test
- Half Year Report and Accounts
- Genetic Technologies 1H FY22 results
- Acquisition of Global Direct to Consumer Ecommerce Business
- Transformational Pathway to US Payer System
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies